Company Filing History:
Years Active: 1996-1998
Title: **Innovator Profile: Paul N. Marshall**
Introduction
Paul N. Marshall is a distinguished inventor based in Santa Clara, California, known for his contributions to the field of blood analysis and diagnostics. With two patented innovations under his belt, Marshall's work focuses on improving the methods of blood differentiation and identification, which have significant implications for hematology and patient care.
Latest Patents
Marshall's latest patent innovations include a **Reagent system and method for the differentiation and identification of whole blood**. This innovative reagent system comprises a reticulocyte staining reagent mixed with a diluent reagent and incubated for a specific period. The resulting mixture undergoes analysis to detect and quantify the light scattering properties of the cells involved. This method allows for efficient differentiation of blood components, improving diagnostic accuracy.
Another notable patent is the **Flow cytometry lytic agent and method enabling five-part leukocyte differential**. In this invention, Marshall describes a specialized lytic agent that swiftly lyses red blood cells while preserving the optical properties of white blood cells for a brief window. This is essential for achieving a reliable five-part leukocyte differential using flow cytometry. The lytic agent's formulation includes key components like 2-phenoxyethanol, which provides leukoprotective and antimicrobial features, alongside TRITON X-100 and TRIS/HCl for optimal performance.
Career Highlights
Paul N. Marshall has made significant strides in the medical diagnostics field during his career at Abbott Laboratories Corporation. His work is characterized by a commitment to advancing technologies that enhance blood analysis and contribute to better healthcare solutions. With his innovative mindset, Marshall exemplifies the qualities of a forward-thinking inventor.
Collaborations
Throughout his career, Marshall has collaborated with notable colleagues, including Robert M. Studholme and Anne M. Embleton. These collaborations have allowed for the cross-pollination of ideas and expertise, ultimately leading to impactful developments in the field of blood diagnostics.
Conclusion
With a focus on enhancing diagnostic processes, Paul N. Marshall continues to be a driving force in the innovation of blood analysis technologies. His patented inventions reflect a dedication to improving healthcare outcomes, showcasing the important role inventors play in the advancement of medical science.